Pharma Bio Serv Stock Probability of Future OTC Stock Price Finishing Over 7.30
| PBSV Stock | USD 0.55 0.06 9.84% |
Pharma |
Pharma Bio Target Price Odds to finish over 7.30
The tendency of Pharma OTC Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 7.30 or more in 90 days |
| 0.55 | 90 days | 7.30 | close to zero percent |
Based on a normal probability distribution, the odds of Pharma Bio to move over $ 7.30 or more in 90 days from now is close to zero percent (This Pharma Bio Serv probability density function shows the probability of Pharma OTC Stock to fall within a particular range of prices over 90 days) . Probability of Pharma Bio Serv price to stay between its current price of $ 0.55 and $ 7.30 at the end of the 90-day period is about 70.29 .
Given the investment horizon of 90 days the otc stock has the beta coefficient of 1.32 indicating as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Pharma Bio will likely underperform. Additionally Pharma Bio Serv has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Pharma Bio Price Density |
| Price |
Predictive Modules for Pharma Bio
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Pharma Bio Serv. Regardless of method or technology, however, to accurately forecast the otc stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the otc stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Pharma Bio's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Pharma Bio Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Pharma Bio is not an exception. The market had few large corrections towards the Pharma Bio's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Pharma Bio Serv, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Pharma Bio within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.12 | |
β | Beta against Dow Jones | 1.32 | |
σ | Overall volatility | 0.06 | |
Ir | Information ratio | -0.01 |
Pharma Bio Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Pharma Bio for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Pharma Bio Serv can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Pharma Bio Serv generated a negative expected return over the last 90 days | |
| Pharma Bio Serv has high historical volatility and very poor performance | |
| Pharma Bio Serv has some characteristics of a very speculative penny stock | |
| About 65.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from express.co.uk: Man Utd rejected Premier League proposal as Sir Jim Ratcliffe faces fan anger |
Pharma Bio Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Pharma OTC Stock often depends not only on the future outlook of the current and potential Pharma Bio's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Pharma Bio's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 22.9 M | |
| Dividends Paid | 3.4 M | |
| Forward Annual Dividend Rate | 0.07 | |
| Shares Float | 12.3 M |
Pharma Bio Technical Analysis
Pharma Bio's future price can be derived by breaking down and analyzing its technical indicators over time. Pharma OTC Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Pharma Bio Serv. In general, you should focus on analyzing Pharma OTC Stock price patterns and their correlations with different microeconomic environments and drivers.
Pharma Bio Predictive Forecast Models
Pharma Bio's time-series forecasting models is one of many Pharma Bio's otc stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Pharma Bio's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the otc stock market movement and maximize returns from investment trading.
Things to note about Pharma Bio Serv
Checking the ongoing alerts about Pharma Bio for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Pharma Bio Serv help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Pharma Bio Serv generated a negative expected return over the last 90 days | |
| Pharma Bio Serv has high historical volatility and very poor performance | |
| Pharma Bio Serv has some characteristics of a very speculative penny stock | |
| About 65.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from express.co.uk: Man Utd rejected Premier League proposal as Sir Jim Ratcliffe faces fan anger |
Additional Tools for Pharma OTC Stock Analysis
When running Pharma Bio's price analysis, check to measure Pharma Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharma Bio is operating at the current time. Most of Pharma Bio's value examination focuses on studying past and present price action to predict the probability of Pharma Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharma Bio's price. Additionally, you may evaluate how the addition of Pharma Bio to your portfolios can decrease your overall portfolio volatility.